Clinical Trials in Chicago

Showing 2661-2680 of 9,860 trials

Improving the Health and Social Participation of People With Disabilities From Underrepresented Groups Post COVID

NCT05792852

This is a single-arm community-based feasibility study examining recruitment, retention, adherence, and satisfaction with ENGAGE, a community-based intervention designed to address pandemic-related social isolation among people with disabilities. We will also examine preliminary, within-group effects on social participation. The findings of this study will inform a larger trial to examine intervention efficacy.

Disabilities Multiple

University of Illinois at Chicago21 participantsStarted Apr 2023

Chicago, Illinois, United States

RECRUITINGPhase 22.2 miles

DALY II USA/ MB-CART2019.1 for DLBCL

NCT04792489

DALY II USA is a phase II, multi-center, single arm study to evaluate the efficacy, safety, and pharmacokinetics of zamtocabtagene autoleucel (MB-CART2019.1) in patients with relapsed and/or refractory diffuse large B cell lymphoma (DLBCL) after receiving at least two lines of therapy. Additional cohorts include subjects with B-cell primary or secondary central nervous system (CNS) lymphoma (PCNSL) and (SCNSL), mantle cell lymphoma (MCL) and Richter's transformation (RT) after receiving at least one line of therapy.

Refractory Diffuse Large B Cell Lymphoma (DLBCL)Relapsed Diffuse Large B Cell LymphomaHigh Grade B-cell Lymphoma (HGBCL)+5 more

Miltenyi Biomedicine GmbH248 participantsStarted May 2021

Gilbert, Arizona, United States • Phoenix, Arizona, United States • La Jolla, California, United States +22 more locations

Improving the Health and Social Participation of People With Disabilities From Underrepresented Groups Post COVID

DALY II USA/ MB-CART2019.1 for DLBCL

Find Trials by Condition in Chicago

Efficacy Study of Nivolumab Compared to Ipilimumab in Prevention of Recurrence of Melanoma After Complete Resection of Stage IIIb/c or Stage IV Melanoma

HiLo: Pragmatic Trial of Higher vs Lower Serum Phosphate Targets in Patients Undergoing Hemodialysis

Our Peers - Empowerment and Navigational Support - Community Living: Remote Peer Navigator Intervention for Adults With Newly Acquired Disabilities Transitioning to Community Living (OP-ENS -CL)

BrotherlyACT: A Tech-Enhanced Violence and Substance Use Intervention for Black Boys and Young Men

Carvedilol in Preventing Heart Failure in Childhood Cancer Survivors

Post-trial Access Program of Idursulfase-IT Along With Elaprase in Children With Hunter Syndrome

A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002)

A Trial of Setanaxib in Patients With Primary Biliary Cholangitis (PBC) and Liver Stiffness

A Multiple-dose Study of ASP8374, an Immune Checkpoint Inhibitor, as a Single Agent and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

Long-term Follow-up Study With Darvadstrocel in the Treatment of Complex Perianal Fistula

Burn Validation Study

FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer

Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD

Treatment of Persistent Atrial Fibrillation With Sphere-9 Catheter and Affera Mapping and Ablation System

Immune-mediated Pathogenic Mechanisms of Neuro-PASC in Veterans

Study of REM-422 in Patients With AML or Higher Risk MDS

Assessment of a Non-invasive Device in the Management of Open Abdomen (AbCLO)

Phase 2b Study of MBS2320 in Participants With Methotrexate-Refractory RA